Clinical Research

Low-dose hydrogen sulfide ameliorates cisplatin-induced hepatotoxicity in rats

Volume: 3 Number: 1 April 30, 2025
EN

Low-dose hydrogen sulfide ameliorates cisplatin-induced hepatotoxicity in rats

Abstract

Objective: Cisplatin (CIS) is non-specific to the cell cycle, has a cytotoxic effect, and is used in many cancers. The side effects of CIS, such as hepatotoxicity, seriously limit its clinical use. This experimental study aims to prevent hepatotoxicity, one of the clinical side effects that cisplatin may cause. At the same time, Hydrogen sulfide (H2S) will be applied prophylactically and therapeutically and its effect levels will be compared. This study aims to contribute to the literature by preventing dose restriction due to the hepatotoxicity side effect of cisplatin, which plays an important role in cancer treatment, by prophylactic application of H2S. Our study investigated the protective and therapeutic efficacy of sodium hydrosulfide (NaHS, a donor of H2S), which activates the antioxidant system on CIS-induced hepatotoxicity. Method: Control (Vehicle), CIS (7.5 mg/kg CIS), H2S+CIS (10 µmol/kg NaHS+7.5 mg/kg CIS), CIS+H2S (7.5 mg/kg CIS+10 µmol/kg NaHS) groups were formed by using 35 rats in the study. At the end of the study, blood and liver tissue was taken, and histopathological and biochemical analyzes were performed. Results: It was determined that sinusoidal dilatation and congestion increased significantly in the CIS group and decreased in the H2S+CIS and CIS+H2S groups. Likewise, glycogen loss occurred in the CIS group, and a significant improvement was observed in the H2S+CIS group. In addition, significant deterioration was detected in malondialdehyde, catalase, glutathione, aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase values in the CIS group compared to the control group. In contrast, significant improvements were observed in both the H2S+CIS and CIS+H2S groups compared to the CIS group. Conclusion: Both protective and therapeutic beneficial effects of H2S in CIS-induced hepatotoxicity were demonstrated by histopathological and biochemical analyses.

Keywords

Supporting Institution

This work was supported by the [2209-A research grant from the Scientific and Technological Research Council of Turkey] under Grant [number 1919B011503776]

Ethical Statement

The study protocol was approved by the Ethics Committee on Animal Research (reference no: 2015/A-84) under the Faculty of Medicine, Inonu University, Malatya, Turkey.

References

  1. Abd Rashid, N., Abd Halim, S. A. S., Teoh, S. L., Budin, S. B., Hussan, F., Adib Ridzuan, N. R., ... (2021). The role of natural antioxidants in cisplatin-induced hepatotoxicity. Biomedicine & Pharmacotherapy, 144, 112328.
  2. Aboraya, D. M., El Baz, A., Risha, E. F., & Abdelhamid, F. M. (2022). Hesperidin ameliorates cisplatin induced hepatotoxicity and attenuates oxidative damage, cell apoptosis, and inflammation in rats. Saudi Journal of Biological Sciences, 29(5), 3157–3166.
  3. Ahmed, M. A. A. S. (2013). The protective effect of ginger (Zingiber officinale) against adriamycin-induced hepatotoxicity in rats: Histological study. Life Science Journal – Acta Zhengzhou University Overseas Edition, 10(1), 1412–1422.
  4. Al-Malki, A. L., & Sayed, A. A. (2014). Thymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa-beta. BMC Complementary and Alternative Medicine, 14(1), 282.
  5. Amirana, S., & Babby, J. (2015). A review of drug-induced liver injury. JNP – Journal for Nurse Practitioners, 11(2), 270–271.
  6. Arslan, A. K., Yaşar, Ş., Çolak, C., & Yoloğlu, S. (2018). WSSPAS: An interactive web application for sample size and power analysis with R using Shiny. Turkiye Klinikleri Journal of Biostatistics, 10(3).
  7. Auten, R. L., & Davis, J. M. (2009). Oxygen toxicity and reactive oxygen species: The devil is in the details. Pediatric Research, 66(2), 121–127.
  8. Azarbarz, N., Shafiei Seifabadi, Z., Moaiedi, M. Z., & Mansouri, E. (2020). Assessment of the effect of sodium hydrogen sulfide (hydrogen sulfide donor) on cisplatin-induced testicular toxicity in rats. Environmental Science and Pollution Research International, 27(8), 8119–8128.

Details

Primary Language

English

Subjects

Medical Pharmacology

Journal Section

Clinical Research

Publication Date

April 30, 2025

Submission Date

September 23, 2024

Acceptance Date

April 17, 2025

Published in Issue

Year 2025 Volume: 3 Number: 1

APA
Ensarioğlu Baktır, K., Günata, M., Özhan, O., Bentli, R., Vardı, N., Türköz, Y., Yıldız, A., Acet, A., & Parlakpınar, H. (2025). Low-dose hydrogen sulfide ameliorates cisplatin-induced hepatotoxicity in rats. Recent Trends in Pharmacology, 3(1), 8-18. https://doi.org/10.62425/rtpharma.1549787
AMA
1.Ensarioğlu Baktır K, Günata M, Özhan O, et al. Low-dose hydrogen sulfide ameliorates cisplatin-induced hepatotoxicity in rats. Recent Trends in Pharmacology. 2025;3(1):8-18. doi:10.62425/rtpharma.1549787
Chicago
Ensarioğlu Baktır, Kudret, Mehmet Günata, Onural Özhan, et al. 2025. “Low-Dose Hydrogen Sulfide Ameliorates Cisplatin-Induced Hepatotoxicity in Rats”. Recent Trends in Pharmacology 3 (1): 8-18. https://doi.org/10.62425/rtpharma.1549787.
EndNote
Ensarioğlu Baktır K, Günata M, Özhan O, Bentli R, Vardı N, Türköz Y, Yıldız A, Acet A, Parlakpınar H (April 1, 2025) Low-dose hydrogen sulfide ameliorates cisplatin-induced hepatotoxicity in rats. Recent Trends in Pharmacology 3 1 8–18.
IEEE
[1]K. Ensarioğlu Baktır et al., “Low-dose hydrogen sulfide ameliorates cisplatin-induced hepatotoxicity in rats”, Recent Trends in Pharmacology, vol. 3, no. 1, pp. 8–18, Apr. 2025, doi: 10.62425/rtpharma.1549787.
ISNAD
Ensarioğlu Baktır, Kudret - Günata, Mehmet - Özhan, Onural - Bentli, Recep - Vardı, Nigar - Türköz, Yusuf - Yıldız, Azibe - Acet, Ahmet - Parlakpınar, Hakan. “Low-Dose Hydrogen Sulfide Ameliorates Cisplatin-Induced Hepatotoxicity in Rats”. Recent Trends in Pharmacology 3/1 (April 1, 2025): 8-18. https://doi.org/10.62425/rtpharma.1549787.
JAMA
1.Ensarioğlu Baktır K, Günata M, Özhan O, Bentli R, Vardı N, Türköz Y, Yıldız A, Acet A, Parlakpınar H. Low-dose hydrogen sulfide ameliorates cisplatin-induced hepatotoxicity in rats. Recent Trends in Pharmacology. 2025;3:8–18.
MLA
Ensarioğlu Baktır, Kudret, et al. “Low-Dose Hydrogen Sulfide Ameliorates Cisplatin-Induced Hepatotoxicity in Rats”. Recent Trends in Pharmacology, vol. 3, no. 1, Apr. 2025, pp. 8-18, doi:10.62425/rtpharma.1549787.
Vancouver
1.Kudret Ensarioğlu Baktır, Mehmet Günata, Onural Özhan, Recep Bentli, Nigar Vardı, Yusuf Türköz, Azibe Yıldız, Ahmet Acet, Hakan Parlakpınar. Low-dose hydrogen sulfide ameliorates cisplatin-induced hepatotoxicity in rats. Recent Trends in Pharmacology. 2025 Apr. 1;3(1):8-18. doi:10.62425/rtpharma.1549787